Identify and Characterize Populations at Risk for Developing Pulmonary Arterial Hypertension (PAH)

Conditions:		Pulmonary Artery Hypertension
Purpose:		This study is looking for high blood pressure in the lungs (Pulmonary artery hypertension PAH) in HIV and COPD patients.
Study Summary:
Criteria:		Inclusion Criteria: - Male/Female 18-80 years of age. - Subject has been previously enrolled in PACT/MAC/ECRC study. - Must have recent ProBNP test >120pg/ml or abnormal echocardiogram (right ventricular systolic pressure >or=40mmHg) without evidence of left sided heart failure. Exclusion Criteria: - Previous diagnosis of congenital heart failure. - If evidence of Left ventricular systolic or diastolic dysfunction, echo will be reviewed by the PI on a case by case basis. - Creatine clearance <60ml/min per 1.73 m2. - Undiagnosed chest pain or myocardial infarction, stroke or cardiovascular event within 3 months. - Pregnancy. - Subjects receiving chronic anticoagulant. - Inability to complete the 6 minute walk test.
NCT ID:		NCT01581086
Primary Contact:		Principal Investigator Hunter C Champion, MD University of Pittsburgh Tammi F Lawther, BS Phone: 412-624-8295 Email: lawthertf@upmc.edu
Backup Contact:		N/A
Location Contact:		Pittsburgh, Pennsylvania 15213 United States *There is no listed contact information for this specific location.* Site Status: Recruiting

Data Source:		ClinicalTrials.gov
Date Processed:		June 19, 2013
Modifications to this listing:		Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"

First Name:

Last Name:

Email Address:

Confirm Email:

Daytime Phone (eg. 555-555-5555):

City:

State:

Zip Code:

Best Time to Call:

Morning	Afternoon	Evening
Please contact me by email instead of calling.

Questions/Comments:

I have read and agree with the Privacy Policy

I have reviewed the eligibility criteria and believe I am eligible for this clinical trial

I would like to be notified about new clinical trials.